Radiopharmaceutical 1 article

A focus on targeted radionuclide therapy separates radiopharmaceutical from adjacent concepts and identifies it as a radionuclide-based therapeutic modality. From implementation to interpretation, radioligand therapy and tumor-targeting radioactive ligands describe the core process, whereas alpha-emitting radionuclides and beta-emitting radionuclides define how the result is used. For entity matching, neighboring methods and products remain separate from the defined concept radiopharmaceutical.